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Abstract
Introduction:  Transurethral, cystoscopically-guided needle core biopsy
(TUcoreBxBT) seems to be a less invasive diagnostic method than transurethral
resection (TURBT) offering a simple way to confirm cancer infiltration of the
bladder. The aim of this study was to assess the technique of TUcoreBxBT in
the diagnosis of bladder cancer infiltrating the detrusor muscle.
Material and methods: In every 96 pts the suspicion of invasive bladder cancer
(IBC) was evaluated on the basis of radiological examinations, cystoscopy and
bimanual examination. TUcoreBxBT were performed using a rigid cystoscope
with a direct working channel and tru-cut automatic (COOK Quick-Core® Biopsy-
Needle) 18 G/480 mm needle or self construction tru-cut 16 G/400 mm needle,
adapted to work with a standard biopsy gun. At least three cores were taken in
each patient, followed by regular TURBT. 
Results: There were no complications of the bladder biopsy procedure. The
average size of cores was 15 mm (8-17 mm). In every case TUcoreBxBT revealed
muscle infiltration and was in agreement with all microscopic examinations of
TURBT.
Conclusions: TUcoreBxBT in cases of clear suspicion of invasive bladder cancer
is a simple, short and safe procedure which makes it possible to collect reliable
material for microscopic examination. TUcoreBxBT is less invasive than standard
TURBT only in diagnosis and staging of invasive tumours, and seems to be
effective in selected cases to confirm malignancy before radical cystectomy.
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Introduction
The most fundamental tool used to distinguish superficial and muscle
invasive bladder cancer (BCa) is properly performed transurethral resection
of the bladder tumour (TURBT). As is widely accepted, in TURBT material
should be taken separately from the tumour, its margins and the bottom
[1, 2]. Diagnosis of invasive bladder cancer (IBC) is usually not difficult.
Infiltration of bladder detrusor revealed by histopathological examination
(H-P) of the TURBT specimen differentiates the BCa character. However,
in some patients with advanced disease, clinical signs known before TURBT
may strongly suggest the presence of muscle invasive tumour. These are
the results of imaging tools, bimanual examination and cystoscopy [3, 4].
Prominent infiltration may be expressed in particular by hydronephrosis,
which may result from deep infiltration of the intramural part of the ureter
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and may be found in ultrasound scan of the
abdomen (TAUS), intravenous urography (IVU) or
computed tomography (CT) [5]. Transurethral
resection of the bladder tumour is then carried out
to confirm the invasive character of BCa, but
histopathological examination may reveal only
cancer cells without muscle tissue. Nevertheless,
imaging procedures, especially CT, carried out before
TURBT allow us to anticipate the presence of IBC.
The question is whether there is any possibility
of TURBT replacement in patients who present with
strong suspicion of invasive character of bladder
tumour revealed by clinical signs, especially by
TAUS, IVU or CT, and who are potential candidates
for radical treatment.
The aim of this study is to present the technique
of bladder tumour transurethral core biopsy
(TUcoreBxBT) in the diagnosis of bladder cancer
infiltrating detrusor muscle, which can replace
diagnostic TURBT of IBC patients.
Material and methods 
Ninety-six patients (87 men and 9 women) aged
between 43 and 79 years (mean age 65 years), who
presented with locally advanced, extensive bladder
tumour suggested by TAUS and CT, were included
in the study. In 72 patients, the above-mentioned
imaging examinations were carried out due to
haematuria only, whereas there were another 14
patients with haematuria and lower urinary tract
symptoms (frequency, painful micturition; LUTS), 
1 patient with LUTS only and 9 experienced lumbar
pain. TAUS, IVU and CT revealed unilateral or
bilateral hydronephrosis associated with bladder
tumour in 51 patients. All patients were potential
candidates for radical cystectomy if the invasive
character of the tumour could be confirmed. The
patients were subjected to TUcoreBxBT just before
the standard TURBT. The procedures were
performed under local spinal anaesthesia and were
preceded by urinary bladder and urethra detailed
endoscopic examination. Tru-cut 16 G, 400 mm in
length (self-made) or 18 G, 480 mm in length (COOK
Quick-Core® Biopsy-Needle) needles put into the
biopsy gun (Bard®Magnum® Instrument MG1522)
were used to carry out biopsy of the bladder tumour
(Figure 1). The needle was speared superficially 
into the tumour and the biopsy gun was released
(Figure 2). At least three cores were taken in each
patient, followed by regular TURBT. Pathological
assessment of tissue cores and TURBT specimens
was done after standard preparation and
haematoxylin-eosin staining. In all patients it was
possible to take tissue cores. All tumours had
exophytic character. The most ‘favourable’ location
of the tumour in terms of the biopsy procedure was
the posterior and lateral walls of the bladder.
All patients were diagnosed with IBC and
subjected to radical cystectomy. The specimens
were then routinely evaluated. Comparison of
histopathological assessment of tissue cores, TURBT
and radical cystectomy specimens was done to
evaluate the clinical significance of TUcoreBxBT. The
type and the grade of the tumour were analysed.
All data were collected after local ethics committee
approval and all patients signed informed consent
previously accepted by the committee.
Results
The quality of all tissue cores gained by
TUcoreBxBT was sufficient to carry out a reliable
histopathological assessment. Length of tissue
cores ranged from 8 mm to 17 mm (mean length 
15 mm). Due to the bladder tumour biopsy,
transitional cell carcinoma (TCC), squamous cell
carcinoma (SCC) and adenocarcinoma were
diagnosed in 92, 3 and 1 patient, respectively. In 12
patients among those with TCC, SCC transformation
was also found. TCC grade was G2 and G3 in 31 and
49 patients, respectively. SCC and AC grades were
assessed as G2 in all cases. Among patients
diagnosed with TCC with SCC transformation, G2
Figure 1. Instruments for transurethral, cystoscopically-guided needle core biopsy (TUcoreBxBT) (A) and the way of
their usage (B)
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grade in 2 cases and G3 grade in 10 cases were
found (Table I). In all patients muscle infiltration was
revealed by histopathological examination of tissue
cores (Figure 3). Histopathological analysis of TURBT
specimens was in complete accordance with
previous tissue core assessment in terms of the
type and the grade of bladder cancer. Muscle
invasion by cancer cells was found in all specimens.
There were no complications specifically associated
with the biopsy procedure. There was also no need
for coagulation of the ‘spear area’ on the surface
of the tumour.
Discussion
The fundamental tool used to evaluate BCa
character (to differentiate between superficial and
muscle invasive bladder tumour) is properly carried
out TURBT and histopathological examination of
the specimen [1, 2]. Clinical staging by imaging tools
is not unquestionable and plays only an additional
role [6]. Transurethral resection of the bladder
tumour is a rather invasive procedure and is
associated with substantial risk of complications,
especially in regard to extensive bladder tumours
[7]. In some patients, muscle infiltration of bladder
tumour may be suspected during cystoscopy (plane
tumour with wide base and no flocks on its surface,
‘inflexibility’ of tumour infiltrating the bladder wall).
Hence, collecting sufficient tissue material to assess
the quantity of muscle tissue in a less invasive
manner is required before eventual radical
cystectomy. It seems that TUcoreBxBT is 
a favourable option in patients who present with
bladder tumour and who are highly suspected to
have muscle involvement due to imaging
procedures (TAUS, IVU) carried out before
cystoscopy [8]. 
There were no complications specifically
associated with the transurethral core biopsy
procedure. It is not possible to exclude such a risk
because the biopsy was followed by regular TURBT,
which would mask their presence. However, one
would not envisage major complications with a few
punctures. The risk of cancer cell spread as
a consequence of TUcoreBxBT remains to be
elucidated. However, it does not preclude carrying
out prostate biopsy in men with high suspicion of
prostate cancer [9]. It is conceivable that the risk of
implantation of cancer cells outside the bladder wall
during TUcoreBxBT should not be greater than in
the case of extensive TURBT.
The idea of using TUcoreBxBT in the diagnosis
of muscle invasive tumours is unique. Trans  -
cutaneous needle core biopsy under ultrasound
control and transurethral core biopsy using
a nephroscope carried out in patients with locally
advanced bladder tumour subjected to neoadjuvant
treatment were presented by Hoshi et al. [10]. It
Figure 2. Endoscopic view of transurethral, cystoscopically-guided needle core biopsy (TUcoreBxBT). A – the needle
before puncturing the right bladder wall tumour, B – the status after the biopsy
Histopathological type  GradingN umber/percentage
of cancer of patients
TCC G2 31 32.3%
G3 49 51.0%
TCC/SCC G2 2 2.0%
G3 10 10.5%
SCC G2 3 3.2%
G3 – –
AC G2 1 1.0%
G3 – –
Total 96 100%
Table I. The results of histopathological examination
of transurethral bladder tumour biopsy cores
(TUcoreBxBT)
AC – adenomatous cancer, SCC – squamous cell cancer, 
TCC – transitional cell cancer, G – grading
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was suggested that the biopsy allowed collection
of enough tissue material to evaluate the tumour
stage and the treatment results. Malmstrom et al.
introduced transcutaneous bladder core biopsy
carried out under CT control in patients who
underwent neoadjuvant chemotherapy due to BCa
in order to collect valuable amounts of tissue
material [11]. 
The results do not suggest that diagnostic TURBT
would be replaced by TUcoreBxBT in all patients
presenting with BCa. It would be very difficult to
find carcinoma in situ. TUcoreBxBT would not be
applied in cases of superficial BCa. On the other
hand, in cases of extensive, solid , muscle infiltrating
bladder tumours it allows for quick, cost-effective,
efficient and less invasive collection of tissue
material for histopathological examination and
qualification for radical therapy. The biopsy carried
out in patients subjected to TURBT carried out just
to confirm tumour invasiveness before radical
cystectomy has obvious advantages: reduced
duration of the procedure, lower probability of
bladder perforation and bleeding, lack of perivesical
lesions observed after TURBT and the possibility of
carrying out the procedure under intravenous
anaesthesia and in an out-patient setting.
Therefore, it is reasonable to suggest that
TUcoreBxBT, which is supposed to invade the
muscle tissue, will simplify the diagnostic procedure
aimed at tumour staging before radical therapy and
make it easier and also less invasive.
In conclusion, transurethral core biopsy of
bladder tumour is indicated only in patients with
large and highly suspected muscle invasive
characteristics of bladder cancer. The biopsy would
serve to confirm the clinical data before planned
radical cystectomy. There are enough clinical data
to know that the tumour infiltrates deeply into the
bladder wall, but to carry out cystectomy,
histological confirmation is still needed. In such
cases, instead of the relatively invasive TURBT, the
biopsy and a few tissue cores may be sufficient to
reveal bladder detrusor involvement. In patients
with less advanced disease, the biopsy would not
bring any benefit.
Endoscopic transurethral needle core bladder
tumour biopsy (TUcoreBxBT) allows collection of
sufficient amounts of tissue material for
histopathological confirmation of detrusor muscle
infiltration.
TUcoreBxBT bladder tumour biopsy carried out
under cystoscopic control is short lasting, efficient,
safe, easy to perform and less invasive than
standard transurethral resection of bladder tumour
(TURBT) carried out in cases of extensive invasive
bladder cancer (IBC).
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